text: Corrado et al. have published an ESC consensus document on the screening of<unk>  for competitive sports. Besides a good medical history and examination, a 12 lead<unk>  is also part of the screening. They have set up special<unk>  criteria for participants in competitive sports (table 1). If one of the described findings are present on the<unk> , the<unk>  is considered 'positive' and further evaluation is mandatory which can include echocardiography, 24-h ambulatory Holter monitoring, and exercise testing.<unk>  Features of cardiac diseases detectable at pre-participation screening in young competitive<unk>  are shown in table 2.       
  Prevalence of<unk>  abnormalities in competitive<unk>  has been studied by Pellicia et al.(see table below).<unk>  abnormalities in their study increased with age and level of exercise. In young amateur<unk>  they found<unk>  abnormalities in about 7%, a number that rised to 40% in "adult elite<unk> ". Especially RBBB and left ventricular hypertrophy were often seen.
  Recently fierce debate has been going on about whether an<unk>  should be part of the screening of apparently healthy young sporters. In Italy this screening is compulsory by law and this country is a strong advocate of the use of an<unk>  as part of this screening. However, others have stated that costs are too high for the yield (expressed in dollars per prevented sudden cardiac death) and an<unk>  is not included in the screening protocol of the American Heart Association.
option_0: EKG in athletes
option_1: Altitude sickness electrocardiogram
option_2: Cardiomyopathy electrocardiogram
option_3: Pulseless electrical activity electrocardiogram
option_4: Haff disease electrocardiogram
option_5: Palpitation echocardiography and ultrasound
option_6: Adams-Stokes syndrome electrocardiogram
option_7: Status asthmaticus electrocardiogram